Ototoxicity Unknown Status Phase 2 Trials for Ebselen (DB12610)

Also known as: Auditory toxicity / Ototoxicity (disorder)

IndicationStatusPhase
DBCOND0008838 (Ototoxicity)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01451853SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing LossTreatment